drugset / Trial / NCT00273416

A Randomized Double Blind, Placebo Controlled Balanced 4-Way Crossover Study To Assess The Efficacy Of Single Oral Doses

NCT00273416

Phase 2 Completed 32 enrolled Pfizer
RandomizedCrossoverDouble-blindTreatment

Summary

The primary aim of this study is to assess how effective PF-00592379 is in restoring penile erections in patients with erectile dysfunction. Patients will attend for 4 treatment visits where they will receive the following in random order; 2 separate doses of PF-00592379, sildenafil 100mg used as a positive control, or placebo (dummy medication). The effect on penile erections will be assessed in the clinic using penile plethysmography (RigiScan PlusTM technique).

Timeline

Start
2006-01
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-00592379 Unknown Oral
Subject Sildenafil Unknown 100 mg Oral

Indications